Age-related mitochondrial dysfunction in Parkinson's disease: New insights into the disease pathology

L Rani, MR Sahu, AC Mondal - Neuroscience, 2022 - Elsevier
Aging is a progressive loss of physiological function that increases risk of disease and
death. Among the many factors that contribute to human aging, mitochondrial dysfunction …

Perspectives of drug-based neuroprotection targeting mitochondria

V Procaccio, C Bris, JMC De La Barca, F Oca… - Revue …, 2014 - Elsevier
Mitochondrial dysfunction has been reported in most neurodegenerative diseases. These
anomalies include bioenergetic defect, respiratory chain-induced oxidative stress, defects of …

The emerging role of energy metabolism and neuroprotective strategies in Parkinson's disease

JW Błaszczyk - Frontiers in aging neuroscience, 2018 - frontiersin.org
Over two centuries ago James Parkinson published “An Essay on the Shaking Palsy”
summarizing his experience with neural pathology now known as Parkinson's disease …

The energy–redox axis in aging and age-related neurodegeneration

LP Yap, JV Garcia, D Han, E Cadenas - Advanced drug delivery reviews, 2009 - Elsevier
Decrease in mitochondrial energy-transducing capacity is a feature of the aging process that
accompanies redox alterations, such as increased generation of mitochondrial oxidants …

Mitochondrial quality control, promoted by PGC‐1α, is dysregulated by Western diet‐induced obesity and partially restored by moderate physical activity in mice

NP Greene, DE Lee, JL Brown, ME Rosa… - Physiological …, 2015 - Wiley Online Library
Skeletal muscle mitochondrial degeneration is a hallmark of insulin resistance/obesity
marked by lost function, enhanced ROS emission, and altered morphology which may be …

Treating neurodegeneration by modifying mitochondria: potential solutions to a “complex” problem

RH Swerdlow - Antioxidants & redox signaling, 2007 - liebertpub.com
Mitochondria function differently in aged brains than they do in young brains. Consistently
reported changes include reduced electron transport chain (ETC) enzyme activities, reduced …

Progresses in both basic research and clinical trials of NAD+ in Parkinson's disease

MJ Perez, P Baden, M Deleidi - Mechanisms of Ageing and Development, 2021 - Elsevier
The decline of nicotinamide adenine dinucleotide (NAD+) levels is a hallmark of aging in
multiple organisms and tissues, including the human brain. Hence, agents that increase …

Mitochondrial quality control and Parkinson's disease: a pathway unfolds

IP de Castro, LM Martins, SHY Loh - Molecular neurobiology, 2011 - Springer
Recent findings from genetic studies suggest that defective mitochondrial quality control may
play an important role in the development of Parkinson's disease (PD). Such defects may …

The importance of mitochondrial quality control for maintaining skeletal muscle function across health span

J Sligar, DA DeBruin, NJ Saner… - American Journal of …, 2022 - journals.physiology.org
As the principal energy-producing organelles of the cell, mitochondria support numerous
biological processes related to metabolism, growth, and regeneration in skeletal muscle …

Mitochondrial dysfunction in astrocytes: a role in Parkinson's disease?

CM Bantle, WD Hirst, A Weihofen… - Frontiers in Cell and …, 2021 - frontiersin.org
Mitochondrial dysfunction is a hallmark of Parkinson's disease (PD). Astrocytes are the most
abundant glial cell type in the brain and are thought to play a pivotal role in the progression …